Serum PSA testing, multiparametric magnetic resonance imaging (mpMRI) and prostatic biopsy constitutes the standard diagnostic pathway for men with suspected prostate cancer in the National Health Service (NHS) in the UK [9]. The gene discussed is KLK3; the disease is prostate carcinoma.